Efficacy and Safety of Amlodipine Used as add-on Therapy in Moderately to Severely Hypertensive Patients Not Adequately Controlled by Olmesartan Medoxomil 20 mg Monotherapy
Phase of Trial: Phase III
Latest Information Update: 02 Jan 2019
At a glance
- Drugs Amlodipine (Primary) ; Olmesartan medoxomil (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Europe
- 05 Jun 2009 Results were published in Clinical Drug Investigation, Volume 29, Number 7, 5 June 2009.
- 29 Oct 2005 New trial record.